Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026)

Zimmer Biomet Holdings' (ZBH) quarterly Other Non-Current Liabilities came in at $630.7 million in Q1 2026, up 358.02% year-on-year from $137.7 million in Q1 2025, and up 0.73% quarter-over-quarter from $626.1 million in Q4 2025.

Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $630.7 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 358.02% year-over-year to $630.7 million in Q1 2026; TTM through Mar 2026 was $630.7 million, a 358.02% increase from a year earlier, with the FY2025 full-year figure at $626.1 million, up 246.49% from the prior year.
  • Other Non-Current Liabilities climbed to $630.7 million in Q1 2026 per ZBH's latest filing, from $626.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.2 billion in Q2 2024 and bottomed at $137.7 million in Q1 2025.
  • The 5-year median for Other Non-Current Liabilities is $630.7 million (2026), against an average of $633.1 million.
  • Across the five-year window, Other Non-Current Liabilities plunged 80.48% in 2024 and surged 358.02% in 2026, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $632.6 million in 2022, then jumped by 46.35% to $925.8 million in 2023, then plunged by 80.48% to $180.7 million in 2024, then surged by 246.49% to $626.1 million in 2025, then climbed by 0.73% to $630.7 million in 2026.
  • Per Business Quant, the three latest ZBH Other Non-Current Liabilities figures stand at $630.7 million (Q1 2026), $626.1 million (Q4 2025), and $806.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Zimmer Biomet Holdings 17.48 Bn 17.07 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 630.70 Mn
Dec 31, 2025 626.10 Mn
Sep 30, 2025 806.40 Mn
Jun 30, 2025 878.80 Mn
Mar 31, 2025 137.70 Mn
Dec 31, 2024 180.70 Mn
Sep 30, 2024 1.03 Bn
Jun 30, 2024 1.21 Bn
Mar 31, 2024 275.80 Mn
Dec 31, 2023 925.80 Mn
Sep 30, 2023 403.10 Mn
Jun 30, 2023 642.00 Mn
Mar 31, 2023 637.40 Mn
Dec 31, 2022 632.60 Mn
Sep 30, 2022 608.70 Mn
Jun 30, 2022 591.00 Mn
Mar 31, 2022 552.50 Mn
Dec 31, 2021 548.50 Mn
Sep 30, 2021 596.60 Mn
Jun 30, 2021 581.60 Mn